U ntil recently, perivascular adipose tissue (PVAT) was regarded as a structural element responsible for support and mechanical protection of the associated vessel. However, in 1991, Soltis and Cassis 1 demonstrated that PVAT influences vascular function by decreasing contractile responses in rat aorta. PVAT is now widely recognized as a functional regulator of vascular tone through its secretion of relaxing and constricting factors acting on the vasculature. Studies have suggested relaxing factors to be nitric oxide (NO), 2 adiponectin, 2-5 angiotensin 1-7, 6,7 prostacyclins, 8 hydrogen sulfide, 9, 10 and hydrogen peroxide (H 2 O 2 ). 11, 12 These factors are counteracted by contracting factors, such as superoxide anion (O 2 · − ), 13 tumor necrosis factor-α, and prostacyclins, 14 and the ultimate regulatory effect on vascular tone is reflected by the balance of PVAT-derived vasoconstrictor and vasodilator factors. 15 
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The final determinant of vascular contraction is the phosphorylation status of myosin light chain 20 (MLC 20 ) , which is regulated by myosin light chain kinase and myosin light chain phosphatase. Myosin light chain phosphatase activity is inhibited by myosin light chain phosphatase regulatory subunit 1 (MYPT1), and myosin light chain kinase activity is regulated by intracellular calcium (Ca 2+ ) concentration. Counterbalancing vascular contraction is the vasodilatory pathway mediated by cyclic GMP-dependent protein kinase G type 1 (PKG-1). 16 Classically, activation of PKG-1 is mediated via endothelium-dependent increases in cyclic GMP, resulting in phosphorylation of big conductance calcium-sensitive potassium channels (BK Ca ) and decreased intracellular Ca 2+ . PKG-1 also phosphorylates RhoA, resulting in reduced Rho kinase activity and consequent reduced phosphorylation of MYPT1. Together, these pathways converge on decreased phosphorylation of MLC 20 and, thereby, reduce vascular contraction. 17 Recent studies have also implicated PKG-1 in the anticontractile effects of PVAT. 5, 18 Adipose tissue comprises 2 subtypes: white (WAT) and brown (BAT) adipose tissues. WAT is known for its capacity to store lipids and its endocrine role, whereas BAT is characterized by energy expenditure in favor of heat generation (nonshivering thermogenesis). Previously thought only to be present in newborns, BAT has recently been identified in adults. 19, 20 In pathologies such as obesity and hypertension, WAT is characterized by low-grade inflammation and is associated with insulin resistance and vascular dysfunction. 21, 22 These changes are also evident in PVAT, where the anticontractile effect is lost, [23] [24] [25] [26] [27] [28] [29] [30] resulting in a procontractile phenotype. 23 We previously demonstrated, in experimental models of obesity-related type 2 diabetes mellitus, that PVAT-derived factors induce endothelial dysfunction and regulate vascular contractility and remodeling. 31 These processes were associated with increased vascular inflammation and vascular smooth muscle cell proliferation. [32] [33] [34] A major source of both O 2 · − and H 2 O 2 are the nicotinamide adenine dinucleotide phosphate oxidases (Nox). Seven isoforms with tissue-specific expression patterns have been identified and characterized, including Nox1, Nox2, Nox3, Nox4, and Nox5 and the dual oxidases 1 and 2.
35 Nox4 is the predominant isoform expressed in murine and human adipocytes. In adipose tissue, however, both Nox2 and Nox4 are expressed at the mRNA level. [36] [37] [38] [39] [40] Nox4 produces mainly H 2 O 2 , whereas the other Nox isoforms produces O 2 · − . This difference has pathophysiological relevance where H 2 O 2 -producing Nox4 activity has been shown to have protective effects on the vasculature, whereas O 2 · − -producing Nox isoforms in many studies are shown to be detrimental. 41, 42 While PVAT of resistance vessels is phenotypically characterized as WAT, the PVAT of the aorta is of a BAT phenotype. 43 Periaortic BAT has anticontractile 1, 26, 44 and anti-inflammatory properties in obesity and may, thus, have vasoprotective effects. 43 In the present study, we examined the role of BAT on vascular function of small resistant arteries, and we elucidated some of the underlying molecular mechanisms whereby BAT influences endothelial function and vascular contractility. Our study focuses on small resistance arteries, important in blood pressure regulation and development of hypertension. Arteries were exposed to adipose tissue from different adipose depots: epididymal visceral adipose tissue (EVAT), which is phenotypically WAT, inguinal subcutaneous adipose tissue (iWAT) and mesenteric PVAT comprising both WAT and BAT, and interscapular adipose tissue, which is solely BAT.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Phenotyping of Adipose Tissue From Different Depots
iWAT, EVAT, and mesenteric PVAT are generally characterized as WAT. However, because WAT can convert into a brown-like phenotype, called beige adipose tissue (BeAT), a small amount of BeAT may be present in adipose tissue classically considered as WAT. To confirm the nature of the adipose tissue that we studied, we investigated the adipose phenotype by analyzing mRNA levels of expression of leptin and transcription factor 21 as markers for WAT, zinc finger of the cerebellum and purinergic receptor P2X5 as specific markers for BAT, and transmembrane protein-26, Cd-137, and T-box protein 1 as specific markers for BeAT. Uncoupling protein-1 and transcription factor Pat2 are joint markers for both BAT and BeAT. These markers have been previously investigated and evaluated in the phenotyping of adipose tissue. 45, 46 Interscapular BAT displayed high expression of brown/ beige markers uncoupling protein-1 and Pat2, as well as the specific markers zinc finger of the cerebellum and purinergic receptor P2X5 ( Figure . Hence, in our study, we used the paradigm that iWAT and PVAT display a mixed adipose phenotype, whereas EVAT is primarily WAT.
BAT Exerts an Anticontractile Effect
Contractile responses of mouse mesenteric arteries were evaluated using wire myography and showed that the presence of iWAT did not affect vascular contraction in response to increasing doses of noradrenaline ( Figure 1A) . The presence of mesenteric PVAT or EVAT increased the sensitivity (EC 50 ) to noradrenaline but did not affect maximum contraction to noradrenaline ( Figure 1B) . However, the presence of BAT markedly reduced contraction to noradrenaline, phenylephrine, or serotonine, demonstrating a potent anticontractile effect ( Figure 1C ; Figure IVA and IVB in the online-only Data Supplement). The anticontractile effect of BAT was independent of sex and background strain ( Figure IVC and IVD in the online-only Data Supplement).
H 2 O 2 Is Among the Anticontractile Factors Produced by BAT
A media transfer approach was used to investigate whether the anticontractile effect of BAT required its immediate localization to the vessel or if the effect was mediated by a secreted factor. Transfer of media preconditioned with BAT displayed a similar anticontractile effect as BAT directly surrounding the vessel ( Figure 1D ), indicating the presence of a diffusible factor, secreted by BAT and acting in a paracrine manner. The presence of polyethylene glycated catalase (PEG catalase), which scavenges H 2 O 2, prevented the anticontractile effect of BAT ( 
BAT Does Not Influence Vascular Relaxation
As demonstrated in Figure VII in the online-only Data Supplement, endothelium-dependent vascular relaxation in response to acetylcholine and endothelium-independent relaxation in response to sodium nitroprusside were not affected by BAT.
Nox4 Plays a Role in BAT-Secreted H 2 O 2
As shown in Figure 2 , Nox4 mRNA levels were increased in BAT and iWAT versus iWAT, but not Nox1 or Nox2. Protein expression of Nox4 was increased only in BAT ( Figure VIIID in the online-only Data Supplement). Because Nox4 is a constitutively active producer of H 2 O 2 , we further explored the possibility that Nox4 may be important in vascular tone regulation by BAT-secreted H 2 O 2 by studying mice deficient for Nox4 gene (Nox4 −/− mice). As shown in Figure 2 , H 2 O 2 levels in all investigated adipose depots were reduced in Nox4 −/− mice ( Figure 2B ). BAT from Nox4 −/− did not exert an anticontractile effect on arteries from wild-type mice ( Figure 2C ), while BAT from wild-type mice exerted an anticontractile effect on arteries from Nox4 −/− mice ( Figure 2D ), demonstrating that the presence of Nox4 in BAT is crucial to induce an anticontractile effect, whereas Nox4 localization in the vessel does not participate in the anticontractile effect of BAT.
Because 
BAT Influences Vascular Function Through H 2 O 2 -Induced Activation of PKG-1
To investigate molecular mechanisms involved in BATinduced anticontractility, we focused on PKG-1, which is activated by reactive oxygen species, such as H 2 O 2 , in vascular smooth muscle cells and which has been shown to attenuate vasoconstriction and promote vasodilation. 47 The anticontractile effect of BAT was abolished in the presence of a potent and selective inhibitor of PKG-1α (DT-3; Figure 3A ). Similar effects were obtained after selective blockade of BK Ca channels by iberiotoxin (Figures 3B). The anticontractile effect was also abolished after PKG inhibitor Rp-8-Br-PET-cyclic GMP and general blockade of Ca 2+ -sensitive potassium channels by tetraethylammonium ( Figure VIC and VID in the onlineonly Data Supplement). However, the effect of BAT was similar after blockade of NO synthesis by Nω-nitro-l-arginine methyl ester hydrochloride ( Figure 3C ) or of cyclic GMP production by ODQ ( Figure 3D ), suggesting that the classical NO-dependent pathway is not involved in mechanisms underlying H 2 O 2 -induced activation of PKG-1. Previous studies demonstrated that PKG-1 is activated by oxidants, which create a disulphide bond in the enzymatic homodimer. 48 We found that BAT from wild-type mice increased dimerization of PKG-1α but BAT from Nox4 −/− mice did not ( Figure 4A ). Furthermore, dithiothreitol, a reducing agent, abolished the anticontractile effect of BAT ( Figure XI in the online-only Data Supplement).
The anticontractile effect of BAT was removed by PEGcatalase and iberiotoxin but not ODQ also with phenylephrine as the contractile agent ( Figure XII in the online-only Data Supplement). We also investigated the potential role of protein kinase A because it may also be activated by oxidants in a similar manner to PKG-1. However, protein kinase A inhibition did not alter the anticontractile effect of BAT ( Figure XIII in the online-only Data Supplement).
BAT Reduces Activation of MYPT1 and MLC 20
To further confirm the anticontractile effect of BAT, we investigated effects of BAT on the activations of MYPT1 and MLC 20 , downstream proteins ultimately responsible for smooth muscle contraction. As shown in Figure 4 , incubation of vascular tissue with BAT resulted in significantly reduced phosphorylation of vascular MYPT1 and MLC 20 ( Figure 4B and 4C).
Differential Mechanisms Underlie the Anticontractile Effects of WAT and BAT
We further investigated whether the molecular pathway identified for BAT was also present in mesenteric PVAT. 
Browning of PVAT Increases the Anticontractile Effect Through H 2 O 2 -Dependent Mechanisms
To elucidate whether the changing of PVAT phenotype into a BAT/BeAT phenotype affects the anticontractile effect, we treated mice with a β 3 agonist, CL-316,243, a well-established method to induce browning in mice. 49 Indeed, β 3 treatment increased BAT/BeAT markers in PVAT ( Figure XV in the online-only Data Supplement), and PVAT from these animals displayed an increased anticontractile effect ( Figure 5A ). The increased anticontractile effect was reduced but not gone after blockade of H 2 O 2 with PEG-catalase and PKG-1α by DT-3 ( Figure 5B and 5C), indicating that the increased anticontractility after browning of resident PVAT is similar in mechanism to that of interscapular BAT.
Discussion
Our study demonstrates that interscapular BAT has anticontractile properties that may be vasoprotective. We elucidated putative novel molecular mechanisms underlying this process and showed that H 2 O 2 released from BAT activates vascular PKG-1α through oxidant-induced dimerization. PKG-1α subsequently phosphorylates BK Ca channels and reduces phosphorylation of MYPT1 and MLC 20 , with pathways ultimately converging to attenuated vascular contraction. These phenomena are BAT-specific because they did not occur in WAT. Importantly, increased browning of PVAT enhances the anticontractile effect, and this increase was shown to be mediated through H 2 O 2 and PKG-1α-dependent mechanisms, demonstrating that increasing the amount of resident BAT can affect vascular function on small resistance vessels. Our study concludes that BAT induces a potent anticontractile effect in small resistant arteries through Nox4-dependent mechanism, in particular H 2 O 2 -induced activation of PKG-1α-dependent signaling.
PVAT of thoracic aorta is primarily a BAT phenotype 43 and has been shown to exert an anticontractile effect, in part through H 2 O 2 . 1,26,44,50 Gao et al 44 reported that effects of aortic PVAT were prevented by catalase and mimicked by H 2 O 2 . This study identified 2 separate pathways of aortic PVAT, an unknown factor inducing endothelium-dependent relaxation and that of H 2 O 2 as the endothelium-independent mechanism. 44 It may be suggested that the presence of 2 mechanisms might reflect the combined effect of both BAT and WAT in aortic PVAT. Mammalian target of rapamycin complex 2 may be partly responsible for aortic PVAT function. In animals lacking rapamycin-insensitive companion of mTOR and, thus, mammalian target of rapamycin complex 2, aortic PVAT anticontractility was impaired, possibly mediated through increased levels of inflammatory cytokines tumor necrosis factor-α and interleukin-6. 51 The observed loss of PVAT function was still evident in denuded arteries, supporting an endothelial-independent mechanism for aortic brown PVAT, which is in accordance with the present study where endothelial denudation did not eliminate the anticontractile effect of BAT. The central player in our described mechanism, H 2 O 2 , has been the focus of intense research, and its role in the vasculature has been extensively reviewed. 52, 53 In the vasculature, H 2 O 2 has been suggested to have both detrimental 54 and protective effects. 41 These conflicting results may be because of differences in subcellular localization of H 2 O 2 and other reactive oxygen species and may relate in part to different cell types, preferentially producing H 2 O 2 . 55, 56 In the present study, H 2 O 2 mediates a protective role, activating PKG-1α, ultimately resulting in reduced vascular contraction. H 2 O 2 can originate from the dismutation of O 2 · − by SOD but also from a dedicated H 2 O 2 producer: Nox4. Because of its vascular localization, 57 constitutively active function, and production of H 2 O 2 , Nox4 is generally regarded as a vasoprotective Nox. Indeed, it is highly expressed in BAT and pivotal to the anticontractile effect we observed because BAT from Nox4 −/− mice failed to exhibit a vascular effect. However, BAT from wild-type mice mediated an anticontractile effect on vessels from Nox4 −/− mice, suggesting that the perivascular production of H 2 O 2 is critical for the anticontractile effect of BAT, rather than H 2 O 2 produced locally in smooth muscle cells in the vascular media. Also, the need for a threshold level of H 2 O 2 is evident because the H 2 O 2 levels were reduced but not abolished in adipose tissue from Nox4 −/− mice, despite the anticontractile effect being abrogated. Importantly, we have previously shown that Nox4 is expressed in human adipocytes. 58 In the present study, vessels devoid of PVAT from Nox4 conditions and after angiotensin II infusion, 41 and basal blood pressure is reduced only after endothelial overexpression of Nox4. 59 Taken together, this suggests that Nox4 may not be a critical regulator of blood pressure under basal conditions but may be important for blood pressure regulation in conditions where it is increased.
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Whether BAT-derived H 2 O 2 mediates an anticontractile effect directly or is determined by downstream signaling through PKG-1α remains unclear. Importantly, H 2 O 2 is known to activate PKG-1α by oxidizing cysteine residues, creating a disulphide bond between the PKG-1α homodimers. Subsequently, there is a conformational change that exposes the phosphorylation site and downstream signaling occurs. Eaton et al demonstrated that mice that do not activate PKG-1α in this manner become hypertensive under normal conditions, 48 demonstrating the importance of the H 2 O 2 -PKG-1α signaling axis in regulating normal blood pressure. In our study, BAT induced dimerization of PKG-1α, but when dimerization was prevented by dithiothreitol, the anticontractile effect was abolished. Interestingly, blockade of H 2 O 2 to PKG-1α signaling by dithiothreitol revealed a procontractile effect of BAT, suggesting that when the beneficial part of H 2 O 2 -dependent signaling is removed, remaining signaling or other procontractile factors such as O 2 · − can exert a vascular contractile action.
In our study, blockade of PKG-1α itself or its downstream target, BK Ca channels, attenuated the anticontractile effect of BAT. This is in accordance with previous studies implicating the BK Ca channels as mediators of the anticontractile effect of adipose tissue. 5 Importantly, Withers et al 18 found the anticontractile effect of PVAT to be absent in mice lacking PKG-1.
Our study highlights the fact that various adipose depots have anticontractile properties but that underlying molecular mechanisms may differ. Previous studies of mesenteric PVAT reported the involvement of voltage-gated potassium channels, 60, 61 in some cases further specifying it to Kv7 K + channels. 9 In the present study, the effect of mesenteric PVAT was inhibited by a voltage-gated potassium channel channel blocker, but the anticontractile effect of BAT was not affected. Similarly, scavenging of H 2 O 2 removed the anticontractile effect of BAT but had no effect on mesenteric PVAT. Additionally, inhibition of mechanisms previously shown to be involved in vasoprotective effects of PVAT, such as hydrogen sulfide, NO, prostacyclins, and angiotensin 1-7 had no effect on the anticontractile effect of BAT. Taken together, these findings suggest that the anticontractile processes of mesenteric PVAT and BAT involve distinct signaling pathways. However, it should also be highlighted that mesenteric PVAT could be mediated by the small degree of BAT or BeAT within the depots commonly characterized as white. 62 Originating from white adipocytes, 63 inactive beige adipocytes localized within WAT can be mobilized into BeAT by exposure to cold or stimulation of β 3 receptors, resulting in a process called browning. Importantly, BeAT is morphologically and functionally similar to classical brown adipocytes. 64 Our phenotyping revealed that although EVAT was characterized as WAT, both PVAT and iWAT displayed BeAT markers and were, thus, characterized as a mix of WAT and BeAT. Interestingly, iWAT did not display an anticontractile effect, and the anticontractile effect of PVAT was not affected by PEG catalase. Either BeAT does not behave in a similar manner to BAT in terms of vascular effect or a critical level of BAT or BeAT needs to be present before the anticontractile effect is functional. To investigate if an increased amount of BeAT may also exert an anticontractile effect, we induced browning through a β 3 agonist. In these mice, PVAT displayed an increased anticontractile effect compared with PVAT from controls, an effect that was sensitive to both scavenging of H 2 O 2 and blockade of PKG-1α, suggesting that the mechanisms of BAT and BeAT may indeed be similar if a critical threshold of BeAT is reached. BAT did not affect vascular relaxation and may relate to the fact that the NO synthase-NO pathway was not influenced by BAT.
From a pathophysiological viewpoint, our findings may be important because several clinical and experimental studies have reported the loss of the PVAT anticontractile effect in obesity, type 2 diabetes mellitus, [27] [28] [29] and hypertension. [23] [24] [25] [26] Patients after bariatric surgery displayed improved insulin sensitivity, reduced blood pressure, and a restored anticontractile effect of PVAT. 2 Interestingly, BAT surrounding the aorta has been reported to be resistant to obesity-induced inflammation, suggesting that BAT may help to protect the vasculature during pathological conditions. Furthermore, transplantation of BAT into the visceral cavity corrects the metabolic phenotype of rodents with diabetes mellitus and metabolic syndrome, and transplantation of BAT has been suggested to be of future importance in metabolic diseases. [65] [66] [67] Based on the novel results of our study, BAT clearly demonstrates a redox-sensitive vasoprotective effect, and as such exposing small arteries to BAT, or increased browning of PVAT, may be an interesting strategy to improve vascular function in pathological conditions.
In conclusion, Nox4 in BAT produces H 2 O 2 , leading to oxidant-induced activation of PKG-1α and its downstream pathway. This pathway ultimately converges to influence signaling that decreases phosphorylation of MYPT1 and MLC 20 , with consequent reduced vascular contraction. Further, we show that browning of PVAT is feasible and identify an anticontractile effect through BAT-mediated processes. Our study provides new insights into mechanisms whereby BAT may exert vasoprotective effects as summarized in Figure 6 . These findings have clinical significance as a novel therapeutic target because PVAT enriched with BAT may preserve vascular function and prevent vascular complications in pathologies, such as hypertension, obesity, and metabolic syndrome.
